Results 41 to 50 of about 488,838 (371)
Scientific Reports, 2021 Intestinal dysbiosis is key in the onset and development of Crohn’s disease (CD). We evaluated the microbiota changes in CD patients before and after a six-month anti-TNF treatment, comparing these changes with the microbiota of healthy subjects.
Laura Sanchis-Artero +11 more
doaj +1 more source
The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases [PDF]
, 2009 INTRODUCTION: Invasive and non-invasive tests can be used to evaluate the activity of inflammatory bowel diseases. OBJECTIVE: The aim of the present study was to investigate the role of fecal calprotectin in evaluating inflammatory bowel disease activity
Bektas, Mehmet +5 more
core +5 more sources
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment [PDF]
Intestinal Research, 2021 Patients with inflammatory bowel disease (IBD) occasionally need a restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) because of medically refractory colitis or dysplasia/cancer.
Shintaro Akiyama +2 more
doaj +1 more source
Frontiers in Immunology, 2022 Crohn’s disease (CD) is a chronic intestinal disorder characterized by refractory gastrointestinal ulcerations. Intestinal tuberculosis (ITB) is one common intestinal disease in east Asia.
Mingshan Jiang +29 more
doaj +1 more source
Irritable bowel syndrome and active inflammatory bowel disease diagnosed by faecal gas analysis [PDF]
, 2016 © 2016 John Wiley & Sons Ltd Background: Inflammatory bowel disease and irritable bowel syndrome may present in a similar manner. Measuring faecal calprotectin concentration is often recommended to rule out inflammatory bowel disease, however, there ...
Aggio +29 more
core +1 more source
Fecal Calprotectin Level as Diagnostic Marker for Intestinal Inflammation in Inflammatory Bowel Disease Patients [PDF]
, 2015 Background: Inflammatory bowel disease diagnosis was still based on invasive examination, such as endoscopy and histopathology. Fecal calprotectin was a non-invasive intestinal inflammation marker, but several study give a different result in its ...
-, Darmadi +3 more
core +3 more sources
History of Inflammatory Bowel Diseases [PDF]
Journal of Clinical Medicine, 2019 Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the intestinal mucosa and unknown etiology. In this review, we identified three main eras in the IBD history. Between the 19th and the 20th century, the primary task had been the definition of the diagnostic criteria in order to differentiate the new entity from intestinal ...
Giovanni Clemente Actis +3 more
openaire +4 more sources
Management of Anal Fistula with Crohn's Disease
Journal of the Anus, Rectum and ColonCrohn's disease (CD) causes gastrointestinal symptoms (i.e., diarrhea and abdominal pain), systemic symptoms (i.e., fatigue, anemia, weight loss, and fever), and perianal fistulas that produce anal pain. Because of the frequent occurrence of diarrhea and
Shota Takano +5 more
doaj +1 more source
World Journal of Surgical Oncology, 2022 Background Colorectal carcinoma with enteroblastic differentiation is a rare subtype of colorectal carcinomas expressing at least one characteristic immunohistochemical marker among α-fetoprotein, glypican-3, and spalt-like transcription factor 4. On the
Takako Kihara +7 more
doaj +1 more source
Cytokines in inflammatory bowel disease [PDF]
Mediators of Inflammation, 1997 Over the past decade, much has been learned regarding the role of various cytokines in the pathogenesis of inflammatory bowel disease. Several cytokine ‘knockout’ models in mice have been shown to develop colitis, while alterations in the production of various cytokines has been documented in human Crohn′s disease and ulcerative colitis.
Beck, P. L., Wallace, J. L.
openaire +5 more sources